Dr. Ruane has nearly 2 decades of experience in drug delivery for combination medical devices. He most recently served as Vice President of R&D at CV Ingenuity (acquired by Covidien) and has held various positions in R&D at Xtent, Cook Group and Navigant Biotechnologies.
Dr. Ruane received his primary degrees in Chemistry from The Galway-Mayo Institute of Technology and Trinity College Dublin, his Ph.D. from University College Dublin and Post-Docs at University of Toronto and The Johns Hopkins University. He is published extensively in both the academic and patent literature.
Chrono Therapeutics (CHRONO) is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) that offers real-time behavioral support. Chrono’s executive leadership combines years of professional experience and personal passions for developing life-saving medical products.
Patrick will describe the technology, the challenges associated with developing this technology (Drug, Medical Device and Technology rolled into a single product) and outline how the technology can be used as a platform for transdermal drug delivery in the treatment of Smoking Cessation, Parkinson’s Disease and Opioid Tapering. He will also discuss Regulatory, Clinical and Business strategy if people are interested, and will bring their product along for you to view.